FDA pauses start of DIAGNODE-3 in the US pending clarification on study drug
The start of the Phase III trial DIAGNODE-3 in the United States is being paused by the US Food and Drug Administration (FDA) to clarify certain outstanding questions regarding the study drug. Diamyd Medical will be notified of which questions that are outstanding within 30 days.A so-called "partial clinical hold" means that the FDA has not yet approved all parts of a study submission. The FDA has informed that it does not yet have sufficient information on questions concerning the study drug. The FDA will within 30 days provide more details on what information needs to be supplemented in
Resurs wants to contribute to a more sustainable society and a more responsible credit market. As a result, we are now launching Resurs Society, which pools all of Resurs’s concrete investments to contribute to a sustainable development for customers, partners, the industry and society as a whole.Resurs is a part of society, and influences it. With this, comes responsibility. As part of raising our ambitions as a partner of society and maintaining a rapid pace in our sustainability activities, we are launching Resurs Society, which will include starting the following initiatives:
-
Lesjöfors’ gas springs business is expanding worldwide. The reasons for this are related to new sales channels and reliable deliveries as well as recovery from last year’s dip in demand caused by corona restrictions. Customers appreciate the high service level greatly.Almost all markets where Lesjöfors offers gas springs show positive sales curves for 2021. Segments worth a special mentioning are the boat and vehicle markets where gas springs often are crucial components.
“Staycation” boosted the boat market
The boat market has